Septerna, Inc.
Status: Publicly traded
Direct answer
Septerna, Inc. is publicly traded on NASDAQ under the ticker SEPN.
Septerna, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to the identification and advancement of orally administered, small molecule therapies that modulate G protein-coupled receptors (GPCRs). The company's pipeline is designed to address a spectrum of conditions within endocrinology, immunology and inflammation, and metabolic disorders. Among its key programs, Septerna is developing...
Can you invest in Septerna, Inc.?
Yes. Septerna, Inc. trades publicly on NASDAQ as SEPN.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Septerna, Inc.
Detailed equity research is provided by MarketSnap.